Termination of Temporary Deferment of Activities Relating to Biologics Submissions and Notice of New Mailing Address; Correction

Samenvatting

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of September 23, 1994 (59 FR 48895). The document announced the termination of temporary deferment of activities relating to biologics submissions and the new mailing addresses for submissions. The document was published with a typographical error. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Mark A. Elengold, Center for Biologics Evaluation Research (HFM-11), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-594-2000. In FR Doc. 94-23617, appearing on page 48895 in the Federal Register of September 23, 1994, the following correction is made: On the same page, in the second column, in the last paragraph, in the fourth line from the bottom ``549-5656'' is corrected the read ``594- 5656''.